With the perks of personalized genetic testing come ethical dilemmas: Do people have a right to information about their own genetic makeup? Should they be able to get it over-the-counter?
The general counsel of Santa Clara-based biotechnology company Affymetrix Inc., Rick Runkel, is wading into that fray as his company moves its research and business interests "downstream," from technologies that help researchers analyze DNA to those that deliver genetic in... (continued)